Mepolizumab exerts crucial effects on glucocorticoid discontinuation in patients with eosinophilic granulomatosis with polyangiitis: a retrospective study of 27 cases at a single center in Japan
Abstract Objectives To investigate the efficacy of mepolizumab in patients with eosinophilic granulomatosis with polyangiitis (EGPA) and factors contributing to glucocorticoid (GC) discontinuation. Methods We retrospectively studied EGPA patients treated with mepolizumab who were on GC at the time o...
| Príomhchruthaitheoirí: | , |
|---|---|
| Formáid: | Alt |
| Teanga: | English |
| Foilsithe / Cruthaithe: |
BMC
2023-06-01
|
| Sraith: | Arthritis Research & Therapy |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1186/s13075-023-03097-5 |